Saxenda (liraglutide) is a prescription-only injectable medication in the same class as Ozempic (semaglutide). However, unlike Ozempic, Saxenda is approved by the Food and Drug Administration (FDA) ...

在2014年，Saxenda已被美国FDA批准，用于肥胖症或超重成人患者。 2020年12月08日讯 /生物谷BIOON/ --诺和诺德（Novo Nordisk）近日宣布 ...

在2015年，Saxenda已在欧盟获批，用于治疗肥胖症或超重成人患者。 2021年03月28日/生物谷BIOON/--诺和诺德（Novo Nordisk）近日宣布 ...

Daphne Berryhill is an oncology pharmacist and freelance writer. She loves the collaborative process of creating health content. Her goal as a writer is to offer information that’s meaningful, ...

新款研究称，诺和诺德的老款减肥药利拉鲁肽（Saxenda）可能导致使用者髋骨、脊柱和前臂的骨密度下降。 每经记者｜蔡鼎 每经编辑｜兰素英 一个月前，有研究称使用“减肥神药”司美格鲁肽的非糖尿病男性更容易出现勃起功能障（Erectile Dysfunction，以下简称 ...

Saxenda (liraglutide) is a prescription drug that’s used to help with weight loss. Saxenda can cause side effects that range from mild to serious. Examples include nausea, vomiting, and diarrhea.

Saxenda and Victoza are brand-name injection pens that contain the same active drug, liraglutide. Saxenda is used for weight management. Victoza is used to treat type 2 diabetes and to lower the risk ...

Saxenda is a brand-name injectable solution prescribed for long-term weight management in adults and some children. It contains the active ingredient liraglutide. Saxenda is not safe to use during ...

These findings further confirm the safety profile of Saxenda and are comparable to the safety data seen at 56 weeks. Novo Nordisk announced that the Food and Drug Administration (FDA) has approved a ...

Patients in the U.S. now have access to the first generic GLP-1 treatment approved for weight loss as Teva has launched its copycat of Novo Nordisk’s injected Saxenda (liraglutide). The compound, ...